Document is current
Any future updates will be listed below
-
Authors
Abul, Yasin
McConeghy, Kevin
DeVone, Frank
Halladay, Christopher
Gravenstein, Stefan
Rudolph, James
- License Information
-
More Information
Article History
Received: 27 March 2025
Revised: 21 July 2025
Accepted: 31 July 2025
First Online: 31 August 2025
Declarations
:
: YA receives or has received grant funding from Abt-CDC, GSK, Sanofi, Moderna. SG has received investigator-initiated grant funding and consulting fees from Sanofi, Genentech, Pfizer, GlaxoSmithKline, Icosavax, Janssen and Seqirus; collaborative grant funding from Moderna; and honoraria and consulting fees from Novavax and Moderna. KWM has received investigator-initiated support from Sanofi, Seqirus, Pfizer, GlaxoSmithKline and Genentech. JR is funded by the VA Health Services Research and Development Center of Innovation in Long-Term Services and Supports (CIN 13-419; C19-20-213). FD and CH have no conflict of interests to report.The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. This work was submitted to be published as an abstract to ID Week 2024.
: This work was supported by the Providence VA Medical Center, Center for Long-Term Services and Supports.
: This work was submitted to be published as an abstract to IDWeek.
